NCT04860986View on ClinicalTrials.gov

A Repeatability and Reproducibility Study of the EarliPoint™ Device

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 7, 2021

Primary Completion Date

November 17, 2021

Study Completion Date

November 17, 2021

Conditions
Autism Spectrum Disorder (ASD)
Interventions
DEVICE

EarliPoint

EarliPoint is a non-invasive diagnostic device for ASD

Trial Locations (1)

30329

Emory University, Atlanta

Sponsors
All Listed Sponsors
lead

EarliTec Diagnostics, Inc

INDUSTRY